NRF3 activates mTORC1 arginine-dependently for cancer cell viability.
Hirose S, Waku T, Tani M, Masuda H, Endo K, Ashitani S, Aketa I, Kitano H, Nakada S, Wada A, Hatanaka A, Osawa T, Soga T, Kobayashi A.
Hirose S, et al. Among authors: hatanaka a.
iScience. 2023 Jan 25;26(2):106045. doi: 10.1016/j.isci.2023.106045. eCollection 2023 Feb 17.
iScience. 2023.
PMID: 36818298
Free PMC article.